EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice

Yuxue Cao, Xiaofan Jiang, Md Moniruzzaman, Alexandra Mueller, Taskeen Iqbal Janjua, Nisha Tyagi, Zhi Qu, Kuan Yau Wong, Yuran Feng, Aayushi Ghodasara, Ekaterina Strounina, Benjamin P Ross und 3 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202520918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuxue Cao und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Insulin, Nanoparticles, Piperazines, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Gastroenterological Society for Australia, Australian Infectious Disease Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biologics have gained prominence as a rapidly advancing therapeutic modality for a diverse spectrum of medical conditions. Nonetheless, they are predominantly administered parenterally due to poor absorption through the gastrointestinal tract. Additionally, repeated injections of biologics such as insulin cause injection pain, leading to dose‐skipping and poor medication adherence. Recently, our group and others have shown that nanoparticle‐based drug delivery systems enhance intestinal permeation and oral delivery of biologics such as insulin and exenatide. However, their effectiveness is not on par with chemical permeation enhancers (PEs) including fatty acids, lipids, and 1‐phenylpiperazine (PPZ), which are toxic at their effective doses. In this work, we report successful PPZ grafting onto silica nanoparticles with no apparent toxicity and significantly increased permeation of macromolecules such as insulin in an in vitro Caco‐2 monolayer model and a co‐culture model. In vivo experiments, with silica‐PPZ‐based novel PE improves the permeation of FITC‐dextran‐4 kDa in healthy mice compared to bare silica nanoparticles and macromolecule alone. In a high‐fat diet mouse model, the use of silica‐PPZ significantly enhances insulin absorption in the intestine. This led to markedly lower and more sustained blood glucose levels compared to controls without any associated toxicity to mice. Overall, we have shown, for the first time, that PPZ‐grafted silica nanoparticles can serve as a safe and effective permeation enhancer for the oral administration of insulin and potentially other biologics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinNanoparticlesPiperazinesDrug Delivery SystemsObesityPiperazineAnimalsMiceHumansAdministration, OralCaco-2 CellsMice, ObeseSilicon DioxideMaleHypoglycemic Agents

Stichwörter der Autor:innen

1‐phenylpiperazinedrug deliveryinsulinoral deliverypermeation enhancerpharmaceutical sciencessilica nanoparticles

Substanzen

InsulinPiperazinesSilicon DioxidePiperazineHypoglycemic Agents

Autor:innen und Institutionen

  • School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
  • Immunopathology Group, Mater Research Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.
  • Centre for Advanced Imaging, The University of Queensland, QLD, Australia.
  • School of Materials Science and Engineering, The University of New South Wales, Sydney, NSW, Australia.

Förderung

  • National Health and Medical Research Council
  • Gastroenterological Society for Australia
  • Australian Infectious Disease Research Centre

Zitieren

APA

Cao, Y., Jiang, X., Moniruzzaman, M., Mueller, A., Janjua, T. I., Tyagi, N., Qu, Z., Wong, K. Y., Feng, Y., Ghodasara, A., Strounina, E., Ross, B. P., Kumeria, T., Hasnain, S. Z., & Popat, A. (2026). Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice. Advanced Science. https://doi.org/10.1002/advs.202520918

Vancouver

Cao Y, Jiang X, Moniruzzaman M, Mueller A, Janjua TI, Tyagi N, et al. Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice. Advanced Science. 2026. doi:10.1002/advs.202520918

BibTeX
@article{Cao2026,
  author = {Cao, Yuxue and Jiang, Xiaofan and Moniruzzaman, Md and Mueller, Alexandra and Janjua, Taskeen Iqbal and Tyagi, Nisha and Qu, Zhi and Wong, Kuan Yau and Feng, Yuran and Ghodasara, Aayushi and Strounina, Ekaterina and Ross, Benjamin P and Kumeria, Tushar and Hasnain, Sumaira Z and Popat, Amirali},
  title = {Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202520918}
}
Kostenlos starten →